http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-2008001610-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf32b60391b469c41e86c353437f5751 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4965 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4045 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-165 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-498 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-165 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4045 |
| filingDate | 2006-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9426d687de798357c3b9a66f4f7007d9 |
| publicationDate | 2008-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | MX-2008001610-A |
| titleOfInvention | USE OF HDAC INHIBITORS FOR THE TREATMENT OF MYELOMA. |
| abstract | The present invention relates to the use of an HDAC inhibitor, especially an HDAC inhibitor of Formula (I), wherein the radicals and symbols have the meanings defined in the specification, for the preparation of a medicament for treatment. myeloma, particularly multiple myeloma, especially myeloma that is resistant to conventional chemotherapy; to a combination comprising an HDAC inhibitor and a compound that affects myeloma cell apoptosis, preferably bortezomib, for simultaneous, separate, or sequential use; to methods for the treatment of myeloma; and to a pharmaceutical composition comprising this combination. |
| priorityDate | 2005-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 214.